This loss of PDK4 expression in cancer is more substantial and prevalent than that of most known tumor suppressors, and collectively, these findings suggest that PDK4 may function as a metabolic tumor suppressor, a possibility that would need to be further explored in an in vivo tumorigenesis study. The gene discussed is PDK4; the disease is neoplasm.